Capital Expenditures - MedCap AB (publ) (STO:MCAP) - Alpha Spread

MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 493 SEK 2.6% Market Closed
Market Cap: 7.4B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Capital Expenditures Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Capital Expenditures
-kr55.6m
CAGR 3-Years
-23%
CAGR 5-Years
-9%
CAGR 10-Years
-24%
AddLife AB
STO:ALIF B
Capital Expenditures
-kr308m
CAGR 3-Years
-49%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Capital Expenditures
-kr291.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Capital Expenditures
-kr138m
CAGR 3-Years
-28%
CAGR 5-Years
-25%
CAGR 10-Years
-14%
G
Genovis AB
STO:GENO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Capital Expenditures
-kr15.1m
CAGR 3-Years
-24%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Capital Expenditures?
Capital Expenditures
-55.6m SEK

Based on the financial report for Jun 30, 2024, MedCap AB (publ)'s Capital Expenditures amounts to -55.6m SEK.

What is MedCap AB (publ)'s Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-24%

Over the last year, the Capital Expenditures growth was -55%. The average annual Capital Expenditures growth rates for MedCap AB (publ) have been -23% over the past three years , -9% over the past five years , and -24% over the past ten years .

Back to Top